Background: Overnight admission after elective percutaneous coronary intervention(PCI)still constitutes the standard approach in most interventional cardiology centers. Advances in PCI techniques have reduced the incidence of post-procedure complications. The objective of this prospective,single-center study was to assess the feasibility, safety, acceptance and cost savings of same-day discharge PCI program. Methods: Eligibility for outpatient management was assessed in 95 consecutive patients undergoing elective PCI from January 2013 to April 2014. Exclusion criteria for early discharge were age>80, severe renal failure, LVEF< 35%, distance from home to hospital >40 km, high risk coronary anatomy or complications during procedure. Major adverse cardiac events,vascular complications and readmission were assessed 1-day and 1-month post discharge. Troponin, EKG and a satisfaction survey were collected within 24 hours post PCI scheduled visit. Results: 39 patients (41%) were cleared for discharge. The remaining 56(59%) stayed overnight for high risk coronary anatomy (n¼51, 91%), chest discomfort (n¼4, 7%) or treatment with abciximab (n¼1, 2%). Mean post PCI hospital stay was 8:48 h for outpatients group. None patient was readmitted. There were no vascular complications. EKG collected in 24-hours-visit show non-specific changes in 3 patients. 7 patients hd troponin elevation without angina or EKG ischemic changes. After one-month follow up only 2 patients had adverse events: a bare metal stent thrombosis (day 7 after procedure) and 1 gastrointestinal bleeding with diagnosis of colonic cancer. These complications could not have been avoided with overnight hospital admission. Early discharge was well valuated with mean patient satisfaction score of 4,5AE0,5 (1 to 5). 87% of outpatients would choose early discharge in case of new PCI. Using diagnosis-related groups costs established in our institution, there were lower cost in the early discharge group, with a mean cost of 2.480 vs 2.880 Euro in the routine care group. Mean of expense savings was 16%. Conclusions: In our experience same-day discharge after elective PCI is feasible, safe and well accepted in selected patients and results in a cost-saving strategy. Cedars-Sinai Heart Institute, Beverly Hills, CA Background: Transplant coronary artery disease (TCAD) is a major cause of mortality in patients after orthotopic heart transplantation (OHT). Use of systemic everolimus has been shown to help prevent allograft vasculopathy in OHT patients. This study examined the clinical and angiographic efficacy, safety, and clinical outcomes of Xience V, a second-generation everolimus-eluting stent (EES), in patients with TCAD. Methods: Post-OHT patients with hemodynamically significant CAD (left main !50% or angiographic diameter stenosis !70%) underwent percutaneous coronary intervention (PCI) with EES. We examined procedural success rates, one-and twoyear mortality, and myocardial infarction rates. Primary end-point was target lesion revascularization (TLR). Surveillance angiography was performed at 1 year and subsequently as clinically indicated on a per-patient basis. Quantitative coronary angiography (QCA) was used for stenosis analysis at baseline, post-procedure, and follow-up. Results: 23 patients were included in the study. PCI was performed in 43 lesions with 45 denovo EES placed. 2 stents were placed into the left main, 20 in the left anterior descending, 12 in the right coronary, and 9 in the left circumflex artery. The average stent length was 17.1AE6.2mm and the average stent diameter was 2.9AE0.6mm. Procedural success rate was 100%. All patients received angiographic follow-up, with average length of follow-up 709AE348 days. There were no periprocedural, 1-year, or 2-year deaths/ MIs. Binary restenosis events were 5.57% (3/45). Target vessel revascularization (TVR) rate was 16.7% (5/30), and TLR rate was 6.98% (3/43).
Conclusions:
Long term follow-up of EES placements in OHT patients with TCAD are associated with a very low incidence of target lesion revascularization. Continued follow-up and further studies are indicated to determine whether EES can positively affect the progression and overall outcome of TCAD.
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Prognostic role of restenosis in 10,004 patients undergoing routine control angiography after coronary stenting Background: Routine control angiography is a valuable tool with high-sensitivity in detecting restenosis after coronary stenting. However, the prognostic role of restenosis is still controversial. We investigated the impact of restenosis on 4-year mortality in patients undergoing routine control angiography after coronary stenting. Methods: All patients undergoing successful implantation of coronary stents for de novo lesions from 1998 to 2009 and routine control angiography after 6 to 8 months at 2 centres in Munich, Germany were studied. Restenosis was defined as diameter stenosis !50% in the in-segment area at follow-up angiography. The primary outcome was 4-year mortality. Abbott Vascular, Santa Clara, CA Background: Chest pain and angina have negative impact on patient quality of life and medical costs. Real-world data describing the incidence of recurrent angina, chest pain and their impact on re-intervention following percutaneous coronary intervention (PCI) are scarce. We sought to describe the incidence and impact of post-PCI angina and chest pain using real-world data from a large claims database. 
